Results 181 to 190 of about 31,215 (290)

A Five-Year Study on Treatment Changes in Hypoglycemia-Associated Medications: Towards Personalized Diabetes Management. [PDF]

J Pers Med
Asiri A, Cahyaningsih I, de Vos S, Bos JHJ, Schuiling-Veninga CCM, Hak E, Mubarik S, Denig P, Taxis K.   +8 more
europepmc   +1 more source

Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3997-4009, May 2026.
Abstract Aims To assess the relationship between haemoglobin A1c (HbA1c) levels and incidence of long‐term complications in patients with type 2 diabetes (T2D). Materials and Methods This long‐term, retrospective study acquired patient data from the Swedish National Diabetes Registry and linked national registers between 1 January 1998 and 31 December ...
Julie Mount, Kristina Boye, Jeremie Lebrec, Emily Wilkes, Kari Ranta, Anders Toll, Erik Joas, Irina Sveide, Björn Eliasson, Josefine Redig   +9 more
wiley   +1 more source

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians. [PDF]

Obes Sci Pract
Aschner P, Henao-Carrillo D.
europepmc   +1 more source

Characterisation of steady‐state pharmacokinetics and glucodynamics of once‐weekly insulin efsitora alfa in individuals with type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4010-4018, May 2026.
Abstract Aims To evaluate the steady‐state pharmacokinetics (PK) and glucodynamic effects of insulin efsitora alfa (efsitora) over a weekly interval in adults with type 2 diabetes (T2D). Materials and Methods This open‐label, multiple dose, euglycaemic clamp study was conducted in 56 insulin naïve adults with T2D (mean [±SD] age, 61.9 ± 5.98 years ...
Jennifer Leohr, Oliver Klein, Tim Heise, Eric Zijlstra, Juliana M. Bue‐Valleskey, Subha Suriyapperuma, Ryan Jarrett, Douglas James, Micheal Case, David Waters, Edward Pratt, Helle Linnebjerg   +11 more
wiley   +1 more source

Two cases (a decade apart) of severe sulfonylurea-positive hypoglycemia associated with inhaled heroin use. [PDF]

JCEM Case Rep
Weisbrot B, Kim KY, Zacharia C, Hwang JL.   +3 more
europepmc   +1 more source

Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12‐month observational cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4082-4090, May 2026.
Abstract Aims To evaluate whether an endocrinology‐integrated transplant clinic and differing healthcare delivery models are associated with metabolic outcomes during the first year after kidney transplantation in recipients with pre‐existing diabetes.
Joaquin Lado‐Abeal, Francisco Gude, Maria Jose Ginzo‐Villamayor, Khalid Al‐Zubaidi, Jacqueline C. Stocking, Gemma Rodriguez‐Carnero, Aili Guo, Prasanth Surampudi, Caroline Lenaerts, Vedesh K. Babu, Deborah Plante, Yihung Huang, Antia Fernandez‐Pombo   +12 more
wiley   +1 more source

Population attributable fraction of associated factors to adherence to blood glucose self-monitoring in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinides: The results of DiaCare study in Iran. [PDF]

J Educ Health Promot
Mohammadi A, Shafiee G, Olyaeemanesh A, Daroudi R, Aghakhani A, Nasli-Esfahani E, Razi F, Heshmat R, Takian A.   +8 more
europepmc   +1 more source

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study [PDF]

, 2009
Jonathan L. Wright, Janet L. Stanford, JS Kasper, KM Waters, SL Bowker, JM Evans, A Vazquez-Martin, Y Zhuang, M Buzzai, I Ben Sahra, RJ Dowling, MB Schneider, M Zakikhani, M Zakikhani, C Algire, I Agalliu, CJ Bailey, TJ Murtola, ME Peek, S Jiralerspong, K Hede, J Hammarsten, J Ma, DG Hardie, SM Hadad, Centers for Disease Control and Prevention (CDC), DM Werny   +26 more
core   +1 more source

Determinants and predictive performance of reduced muscle mass in elderly patients with type 2 diabetes: a retrospective study. [PDF]

Front Endocrinol (Lausanne)
Wang K, Fu W, Pan H, Dong J.
europepmc   +1 more source

Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4112-4120, May 2026.
ABSTRACT Aims Evogliptin, a dipeptidyl peptidase‐4 inhibitor with a glucose‐dependent mechanism of action, is widely used as a monotherapy or in combination with other agents. However, observational studies in routine clinical settings remain limited.
Jun Hwa Hong, Sung Hoon Yu, Ki‐Hyun Baek, JaeMyung Yu, Seung Jin Lee, Hyung‐Wook Kim, Kang Seo Park, Jung Han Kim, KyungWan Min, Yong Hwan Lee, Koon Soon Kim, Min Soo Song, Ji Hoon Kim, Jie‐Eun Lee, Jong Chul Won   +14 more
wiley   +1 more source